The objective is to map the pharmacokinetic / pharmacodynamic interaction between
dexmedetomidine and remifentanil by observing changes in anesthetic depth. These changes will
be related to drug concentrations using pharmacokinetic/pharmacodynamic (PKPD) modeling.